Non-Small Cell Lung Cancer

Filter By:
http://cance... For ALK+ lung cancer patients, brain metastases are a common concern. Dr. Robert Doebele discusses the options available to treat brain mets as well as drugs that may break through the blood/brain barrier. February 2014 GRACEcast 271 Lung
by:cancergrace | 48 views
During the Saturday press conference at ESMO2014, Professor David Currow describes results of Phase III data showing that a new drug, anamorelin, improves appetite and body mass in patients with advanced lung cancer, who are suffering cancer anorexia and cachexia. In the ROMANA studies, patients ...
by:EMJ | 184 views
http://cance... For patients with wild type EGFR, meaning there is no EGFR mutation, drugs like Tarceva (erlotinib) can have a small benefit, but Dr. Joan Schiller wants research to do better. February 2014 GRACEcast 270 Lung
by:cancergrace | 1231 views
http://cance... Eighty percent of lung cancer patients have wild type EGFR, meaning there is no EGFR mutation. Dr. Joan Schiller of UT Southwestern Medical Center discusses a new drug in development that may help those patients. February 2014 GRACEcast 269 Lung
by:cancergrace | 1040 views
Download from iTunes: https://itun... Lung cancer is being fought on three fronts at MD Anderson Cancer Center: prevention, early detection and treatment of advanced disease. John Heymach, M.D., Ph.D., professor in Thoracic/Head and Neck Medical Oncology at MD Anderso...
by:mdanderson | 84 views
http://cance... The stigma of lung cancer can lead to shame, fear, and sub-optimal care. Dr. Joan Schiller wants us all to get past it, and she's leading the charge to make that happen. February 2014. GRACEcast 268 Lung
by:cancergrace | 748 views
http://cance... Does it make sense to do molecular testing on early stage lung cancer patients? Dr. Taofeek Owonikoko of Emory University School of Medicine and the Winship Cancer Institute thinks it does in some settings. February 2014 GRACEcast 267 Lung
by:cancergrace | 1492 views
http://cance... Will the success seen for stage IV patients receiving targeted therapies translate into cure for stage III patients? Dr. Daniel Morgensztern of the Washington University School of Medicine talks about what research is ongoing to answer that question. GRACEcast 266 Lung
by:cancergrace | 1400 views
Patients with cancer undergoing chemotherapy and radiation may be at risk for Oral Mucositis, a condition characterized by redness, inflammation and ulcer like sores throughout the mouth and throat. Oral Mucositis can be extremely painful and may also lead to infection. The following tips can be hel...
by:DARABioSciences | 1412 views
http://cance... Thanks to research, Dr. Daniel Morgensztern of the Washington University School of Medicine sees reason to be hopeful in the fight against lung cancer. February 2014 GRACEcast 264 Lung
by:cancergrace | 2266 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)